Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Shiema Abdalla"'
Autor:
Hamad Abdel Hadi, Soha R. Dargham, Faiha Eltayeb, Mohamed O. K. Ali, Jinan Suliman, Shiema Abdalla M. Ahmed, Ali S. Omrani, Emad Bashir Ibrahim, Yuzhou Chen, Clement K. M. Tsui, Sini Skariah, Ali Sultan
Publikováno v:
Antibiotics, Vol 13, Iss 4, p 320 (2024)
Antimicrobial resistance is a global healthcare threat with significant clinical and economic consequences peaking at secondary and tertiary care hospitals where multidrug-resistant Gram-negative bacteria (MDR GNB) lead to poor outcomes. A prospectiv
Externí odkaz:
https://doaj.org/article/43e52ce227154d5ca63d1557a616bd87
Autor:
Rand A. Alattar, Shiema Abdalla, Tasneem Abdallah, Rashid Kazman, Aseelah Qadmour, Tawheeda Ibrahim, Bassem Alhariri, Shahd H. Shaar, Abeer Bajwa, Abeir Alimam, Rabia Qazi, Fatma Ben Abid, Joanne Daghfal, Ali Eldeeb, Kinda Shukri, Ahmed Elsayed, Fatima Rustom, Musaed Alsamawi, Alaaeldin Abdelmajid, Miguel A.P. Basulto, Armando A.R. Cobian, Mohamed Abukhattab, Abdullatif Alkhal, Muna A. Almaslamani, Ali S. Omrani
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 10, Pp 1061-1064 (2022)
We retrospectively investigated the clinical outcomes of favipiravir in patients with COVID-19 pneumonia. Patients who between 23 May 2020 and 18 July 2020 received ≥ 24 h of favipiravir were assigned to the favipiravir group, while those who did n
Externí odkaz:
https://doaj.org/article/336874a116ad4e1e96c28f1cefe4923e
Autor:
Ahmad Al Bishawi, Shiema Abdalla, Marwa Askar, Wael Kanjo, Amal Sameer, Gihan Mustafa, Hamad Abdel Hadi, Muna Al Maslamani, Alaaeldin Abdelmajid
Publikováno v:
Clinical Case Reports, Vol 10, Iss 5, Pp n/a-n/a (2022)
Abstract Infection following SARS‐Co V‐2 leading to COVID‐19 disease is associated with significant morbidity and mortality. The clinical entity, COVID‐19 cytokine storm syndrome (CSS) is a severe immunological manifestation of the disease as
Externí odkaz:
https://doaj.org/article/06cb8231d0f84b81939c32ecdadfffa7
Autor:
Ali S. Omrani, Muna A. Almaslamani, Joanne Daghfal, Rand A. Alattar, Mohamed Elgara, Shahd H. Shaar, Tawheeda B. H. Ibrahim, Ahmed Zaqout, Dana Bakdach, Abdelrauof M. Akkari, Anas Baiou, Bassem Alhariri, Reem Elajez, Ahmed A. M. Husain, Mohamed N. Badawi, Fatma Ben Abid, Sulieman H. Abu Jarir, Shiema Abdalla, Anvar Kaleeckal, Kris Choda, Venkateswara R. Chinta, Mohamed A. Sherbash, Khalil Al-Ismail, Mohammed Abukhattab, Ali Ait Hssain, Peter V. Coyle, Roberto Bertollini, Michael P. Frenneaux, Abdullatif Alkhal, Hanan M. Al-Kuwari
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at a national level, and none after 60 days of follow up. The aim of this study was to describe national, 60-day all-cause mortality associated with COVID-19,
Externí odkaz:
https://doaj.org/article/6612c6657af94d62977b05f6b4576148
Publikováno v:
IDCases, Vol 22, Iss , Pp e00935- (2020)
Coronavirus Disease 2019 (COVID-19)-associated pulmonary aspergillosis is an emerging entity. We report two fatal cases of putative COVID-19-associated pulmonary aspergillosis. Both cases were diagnosed on the basis of respiratory tract cultures yiel
Externí odkaz:
https://doaj.org/article/beac28c87d0c43daaeb944891a50b1d3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ahmad Al Bishawi, Shiema Abdalla, Marwa Askar, Wael Kanjo, Amal Sameer, Gihan Mustafa, Hamad Abdel Hadi, Muna AlMaslamani, Alaaeldin Abdelmajid
Our patient is a 39-year-old male with normal baseline blood parameters who presented with COVID-19 infection, associated with neutropenia and then progressed to critical disease culminating into CSS. Based on risks and benefits evaluation, he was tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fb741ff72e8e34cc3ae57a1ad7710f6
https://doi.org/10.22541/au.165098845.52373828/v1
https://doi.org/10.22541/au.165098845.52373828/v1
Autor:
Fatima Rustom, Rand A. Alattar, Ali M. Eldeeb, Rashid Kazman, Shiema Abdalla, Fatma Ben Abid, Abeir Bh Alimam, Shahd H. Shaar, Ali S. Omrani, Musaed Alsamawi, Aseelah Qadmour, Tasneem A.K. Abdallah, Miguel A. Paulino Basulto, Joanne Daghfal, Alaaeldin Abdelmajid, Abeer Bajwa, Kinda Shukri, Mohamed Abukhattab, Bassem Alhariri, Armando Ar Cobian, Rabia Qazi, Tawheeda B. H. Ibrahim, Muna Almaslamani, Ahmed Elsayed, Abdullatif Al-Khal
BackgroundWe investigated clinical outcomes of favipiravir in patients with COVID-19 pneumonia.MethodsPatients who between 23 May 2020 and 18 July 2020 received ≥24 hours of favipiravir were assigned to the favipiravir group, while those who did no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5f42e2b27b5b559c0e3385482964d02
https://doi.org/10.1101/2021.11.29.21267042
https://doi.org/10.1101/2021.11.29.21267042
Background: A highly contagious virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a pandemic globally. HIV medications were one of the suggested treatments for Coronavirus disease 2019 (COVID-19). Here, we report an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b83e507801c0c7d633d45b7a748386a
https://doi.org/10.21203/rs.3.rs-77527/v1
https://doi.org/10.21203/rs.3.rs-77527/v1
Autor:
Mohamed A. Sherbash, Dana Bakdach, Ali Ait Hssain, Tawheeda B. H. Ibrahim, Venkateswara R. Chinta, Shiema Abdalla, Shahd H. Shaar, Abdullatif Al Khal, Fatma Ben Abid, Roberto Bertollini, Mohamed Elgara, Ahmed Zaqout, Khalil Al-Ismail, Mohammed Abukhattab, Abdelrauof M. Akkari, Hanan M. Al kuwari, Sulieman Abu Jarir, Ahmed Husain, Ali S. Omrani, Peter Coyle, Anvar Hassan Kaleeckal, Rand A. Alattar, Reem Elajez, Anas Baiou, Mohamed Badawi, Kris Choda, Bassem Alhariri, Michael P. Frenneaux, Joanne Daghfal, Muna Almaslamani
BackgroundThere are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at a national level, and none after 60 days of follow up. The aim of this study was to describe national, 60-day all-cause mortality associated with COVID-19, and to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aae6be4986da7d46c2b07246b937872